These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37063459)

  • 1. Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression.
    Guermazi A; Roemer FW; Crema MD; Jarraya M; Mobasheri A; Hayashi D
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231165558. PubMed ID: 37063459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.
    Roemer FW; Kwoh CK; Hayashi D; Felson DT; Guermazi A
    Nat Rev Rheumatol; 2018 Jun; 14(6):372-380. PubMed ID: 29752462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A call for screening MRI as a tool for osteoarthritis clinical trials.
    Guermazi A; Roemer FW; Jarraya M; Hayashi D
    Skeletal Radiol; 2023 Nov; 52(11):2011-2019. PubMed ID: 37126081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
    Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014.
    Eckstein F; Le Graverand MP
    Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to effectively utilize imaging in disease-modifying treatments for osteoarthritis clinical trials: the radiologist's perspective.
    Hayashi D; Roemer FW; Guermazi A
    Expert Rev Mol Diagn; 2021 Jul; 21(7):673-684. PubMed ID: 34015975
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on recent developments in imaging of inflammation in osteoarthritis: a narrative review.
    Hayashi D; Roemer FW; Jarraya M; Guermazi A
    Skeletal Radiol; 2023 Nov; 52(11):2057-2067. PubMed ID: 36542129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of OA - From disease modification to clinical utility.
    Hayashi D; Roemer FW; Eckstein F; Samuels J; Guermazi A
    Best Pract Res Clin Rheumatol; 2020 Dec; 34(6):101588. PubMed ID: 32943330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials.
    Manno RL; Bingham CO; Paternotte S; Gossec L; Halhol H; Giacovelli G; Rovati L; Mazzuca SA; Clegg DO; Shi H; Tajana Messi E; Lanzarotti A; Dougados M
    Osteoarthritis Cartilage; 2012 Feb; 20(2):93-101. PubMed ID: 22178465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative.
    Ried JS; Flechsenhar K; Bartnik E; Crowther D; Dietrich A; Eckstein F
    Arthritis Rheumatol; 2015 Dec; 67(12):3174-83. PubMed ID: 26314914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: Data from the Osteoarthritis Initiative.
    Flechsenhar K; Ried JS; Driban JB; Price LL; McAlindon T
    Semin Arthritis Rheum; 2019 Aug; 49(1):3-8. PubMed ID: 30611544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is knee radiography useful for studying the efficacy of a disease-modifying osteoarthritis drug in humans?
    Mazzuca SA; Brandt KD
    Rheum Dis Clin North Am; 2003 Nov; 29(4):819-30. PubMed ID: 14603585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchondral bone in knee osteoarthritis: bystander or treatment target?
    Kasaeian A; Roemer FW; Ghotbi E; Ibad HA; He J; Wan M; Zbijewski WB; Guermazi A; Demehri S
    Skeletal Radiol; 2023 Nov; 52(11):2069-2083. PubMed ID: 37646795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
    Jotanovic Z; Mihelic R; Sestan B; Dembic Z
    Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?
    Roubille C; Pelletier JP; Martel-Pelletier J
    Expert Opin Pharmacother; 2013 Oct; 14(15):2059-77. PubMed ID: 24044485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of osteoarthritis-recent research developments and future perspective.
    Hayashi D; Roemer FW; Guermazi A
    Br J Radiol; 2018 May; 91(1085):20170349. PubMed ID: 29271229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging for osteoarthritis.
    Hayashi D; Roemer FW; Guermazi A
    Ann Phys Rehabil Med; 2016 Jun; 59(3):161-169. PubMed ID: 26797169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES).
    Roemer FW; Collins J; Kwoh CK; Hannon MJ; Neogi T; Felson DT; Hunter DJ; Lynch JA; Guermazi A
    Osteoarthritis Cartilage; 2020 Jan; 28(1):71-81. PubMed ID: 31513920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug.
    Sabha M; Siaton BC; Hochberg MC
    Expert Opin Investig Drugs; 2020 Dec; 29(12):1339-1346. PubMed ID: 33096010
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on the evolution of semi-quantitative MRI assessment of osteoarthritis: Past, present and future.
    Roemer FW; Jarraya M; Hayashi D; Crema MD; Haugen IK; Hunter DJ; Guermazi A
    Osteoarthritis Cartilage; 2024 Apr; 32(4):460-472. PubMed ID: 38211810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.